Absence of gallium uptake in multicentric Castleman's disease of plasma cell type
Chim, C.S.; Choi, F.P.; Ooi, G.C.; Kwong, Y.L.
Haematologica 86(4): 442-443
2001
ISSN/ISBN: 0390-6078 PMID: 11325657 Document Number: 536969
Multicentric Castleman's disease (MCD) of plasma cell type is a reactive lymphoproliferative disease. While 67Ga scanning is useful in the detection of malignant lymphomas, its role in reactive lymphadenopathy is unknown. We report the absence of 67Ga uptake in three patients with MCD of plasma cell type and present a review of the English literature on this condition.
Document emailed within 1 workday
Related Documents
Nakamura, T.; Sato, K.; Harada, N.; Sakuramoto, M.; Miyahara, R.; Maekawa, T.; Fukuda, S. 1997: Plasma cell interstitial pneumonia as a manifestation of multicentric Castleman's disease Nihon Kyobu Shikkan Gakkai Zasshi 35(7): 776-783Stanley, M.W.; Frizzera, G.; Dehner, L.P. 1986: Castleman's disease, plasma-cell type. Diagnosis of central nervous system involvement by cerebrospinal fluid cytology Acta Cytologica 30(5): 481-486
Skelton, H.G.; Smith, K.J. 1998: Extranodal multicentric Castleman's disease with cutaneous involvement Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 11(1): 93-98
Batra, Y.; Choudhry, A.; Gupta, S.D. 1999: A case of multicentric angio-follicular lymph node hyperplasia (Castleman's disease) Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 20(4): 180-181
Adam, Zěk.; Szturz, P.; Koukalová, R.; Řehák, Zěk.; Pour, Lěk.; Krejčí, M.; Šmardová, L.; Eid, M.; Volfová, Pína.; Čermáková, Zňka.; Křen, Lš.; Sokol, F.; Hanke, I.; Michalková, E.; Král, Zěk.; Mayer, Jří. 2015: PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review Vnitrni Lekarstvi 61(3): 251-259
Yamac, K.; Senol, E.; Ataoglu, O.; Fen, T. 2001: A case report of multicentric Castleman's disease with simultaneous Epstein-Barr virus infection Tumori 87(5): 343-345
Tang, J.; Wilson, C.M.; Schaen, M.; Myracle, A.; Douglas, S.D.; Kaslow, R.A. 2002: CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy Aids Research and Human Retroviruses 18(6): 403-412
Collery, P.; Domingo, J.L.; Keppler, B.K. 1996: Preclinical toxicology and tissue gallium distribution of a novel antitumour gallium compound: tris (8-quinolinolato) gallium (III) Anticancer Research 16(2): 687-691
Cakir, E.; Aydin, N.E.; Samdanci, E.; Karadag, N.; Sayin, S.; Kizilay, A. 2013: Follicular dendritic cell sarcoma associated with hyaline-vascular Castleman's disease JPMA. Journal of the Pakistan Medical Association 63(3): 393-395
Mehta, J.; Desphande, S.; Stauffer, J.L.; Stanford, R.; Fernandez, E. 1980: Plasma cell granuloma of the lung: endobronchial presentation and absence of response to radiation therapy Southern Medical Journal 73(9): 1198-1201
Bulum, T.; Prkacin, I.; Blaslov, K.; Zibar, K.; Duvnjak, L. 2013: Association between red blood cell count and renal function exist in type 1 diabetic patients in the absence of nephropathy Collegium Antropologicum 37(3): 777-782
Ho Ngoc-Ta Trung, A.; Sirois, G. 1987: Influence of plasma pH on quinidine uptake by erythrocytes: estimation of free drug fraction in plasma from blood/and erythrocyte/plasma concentration ratios Pharmaceutica Acta Helvetiae 62(2): 61-64
Nutt, C.L.; Chambers, A.F.; Cairncross, J.G. 1996: Wild-type p53 renders mouse astrocytes resistant to 1,3-Bis(2-chloroethyl)-1-nitrosourea despite the absence of a p53-dependent cell cycle arrest [corrected Cancer Research 56(12): 2748-2751
Pfueller, S.L.; Weber, S.; Lüscher, E.F. 1977: Studies of the mechanism of the human platelet release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma Journal of Immunology 118(2): 514-524
Takii, T.; Hayashi, H.; Marunouchi, T.; Onozaki, K. 1994: Interleukin-1 down-regulates type I interleukin 1 receptor mRNA expression in a human fibroblast cell line TIG-1 in the absence of prostaglandin E2 synthesis Lymphokine and Cytokine Research 13(3): 213-219
Kornstein, M.J.; deBlois, G.G.; Williams, M.E. 1992: Unusual biclonal plasma cell dyscrasia with crystallike inclusions producing colonic tumors (plasma cell polyposis) and terminating in T-cell lymphoma Archives of Pathology and Laboratory Medicine 116(2): 168-172
Wüstner, H.; Orfanos, C.; Gartmann, H. 1975: Multicentric, disseminated reticulohistiocytosis with plasma cells[ Zeitschrift für Hautkrankheiten 50(19): 819-820
Ghosal, D.Prasanna.; Lahiri, S.; Bandyopadhyay, D.; Deb, J. 2012: Castleman's disease--a rare disease with varying presentation Journal of the Indian Medical Association 110(5): 331
Drut, R. 1996: Coexistence of Hodgkin's disease and Castleman's disease Archives of Pathology and Laboratory Medicine 120(12): 1084
Fernández de la Puebla Giménez, R.A.; Torres Serrano, F.; Manzanares Escribano, R.; López Rubio, F. 1990: Retroperitoneal Castleman's disease Medicina Clinica 95(20): 795